🔬 Beyond Blood Pressure: RAS Inhibitors Reducing Inflammatory Markers💡
The renin–angiotensin system plays a central role in regulating blood pressure and inflammation 🧬💊. Medications known as Renin-Angiotensin System Inhibitors are widely used to manage cardiovascular conditions and may also influence inflammatory processes. A systematic review and meta-analysis of randomized controlled trials examined how these drugs affect inflammatory markers 🔬📊. Results indicate reductions in biomarkers such as C-reactive protein and cytokines, suggesting potential anti-inflammatory benefits beyond blood pressure control. These findings highlight the broader therapeutic value of renin–angiotensin system inhibitors ❤️💡. By reducing inflammation, these medications may improve cardiovascular outcomes, support vascular health, and offer additional protection for patients with hypertension and metabolic-related disorders. Health Scientists Awards🏆 Visit Our Website🌐: healthscientists.org/ Nomination👍: https://healthscientists.org/award-nomination/...